BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Pharm Country

  Tamandare Explorations Inc. Announces Name Change to Tonix Pharmaceuticals Holding Cor

  October 20, 2011

   · 

  1 min read
• Business

  RTI Biologics Schedules 2011 Third Quarter Earnings and Conference Call for Oct. 27, 2011

  October 20, 2011

   · 

  1 min read
• Drug Development

  ImmunoGen, Inc. Earns Milestone With Start of SAR3419 Phase II Testing

  October 20, 2011

   · 

  1 min read
• Business

  Merge Healthcare Sets Third Quarter 2011 Earnings Call

  October 20, 2011

   · 

  1 min read
• Business

  ImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2012 Financial Results

  October 20, 2011

   · 

  1 min read
• Business

  Vitrolife: Conference Call on the Report on Interim Report

  October 20, 2011

   · 

  1 min read
• Business

  Imagen Biotech Banks $40 Million to Advance Ophthalmology Therapies

  October 20, 2011

   · 

  6 min read
• BioCapital

  Ex-Lee Research Institute Employees Admit to Falsifying Data

  October 20, 2011

   · 

  1 min read
• Business

  Patheon Signs Three Year $18 Million Development Agreement with Boehringer Ingelheim Corporation

  October 20, 2011

   · 

  1 min read
• Drug Development

  Genentech’s Phase II Study Showed Ocrelizumab Maintained Significant Reduction in Disease Activity for Multiple Sclerosis Patients for Almost Two Years

  October 20, 2011

   · 

  1 min read